Browsing Tag
HIND
1 post
Vyome completes merger with ReShape Lifesciences, to debut on Nasdaq as Vyome Holdings (HIND) on August 15
Vyome merges with ReShape Lifesciences, will trade on Nasdaq as Vyome Holdings (HIND) from August 15, focusing on immuno-inflammatory and rare diseases.
August 15, 2025